Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapy

Autor:	Young Suk Lee, Tae-Hun Kim, Haak Cheoul Kim, Joon Yeol Han, Myung Seok Lee, Byung Chul Yoo, Mong Cho, Young Soo Kim, Seong Gyu Hwang, Soon Ho Um, Byung Hoon Han, Cheol Ju Han, Young Hwa Chung, Heon Ju Lee, Se Hyun Cho, Kwon Yoo, Kwan Soo Byun, Hyo Suk Lee, Seung Woon Paik, Kwang Cheol Koh, Ju Hyun Kim, Chae Yoon Chon, Jin Mo Yang, Hee Won Yoo, Soo Hyung Ryu, Byung Ik Kim, Jae Seok Hwang, Kwan Sik Lee
Rok vydání:	2010
Předmět:	Hepatitis B virus HBsAg medicine.disease_cause Antiviral Agents Humans Medicine Hepatitis B e Antigens Hepatitis Hepatitis B Surface Antigens business.industry Arabinofuranosyluracil Gastroenterology virus diseases Alanine Transaminase Viral Load Hepatitis B medicine.disease Virology digestive system diseases Titer HBeAg Clevudine DNA Viral business Viral load Follow-Up Studies medicine.drug
Zdroj:	Journal of Gastroenterology. 46:410-414
ISSN:	1435-5922 0944-1174
DOI:	10.1007/s00535-010-0354-x
Popis:	This study was conducted to evaluate the durability of clevudine-induced viral response after the withdrawal of treatment. Patients who showed a complete response [alanine aminotransferase (ALT) normalization and hepatitis B virus (HBV) DNA
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d715a2277ad4254596472a59d3a7a7f https://doi.org/10.1007/s00535-010-0354-x Zobrazit plný text záznamu Full text from SpringerLink